SCHEDULE: TD Bank Group Discloses UroGen Pharma Stake

The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.

Summary

• The Toronto-Dominion Bank (TD Bank) and its subsidiary TD Securities Inc. (TDSI) have jointly filed an amended Schedule 13G.
• This filing indicates their beneficial ownership of 3,371,263 ordinary shares of UroGen Pharma Ltd.
• This represents approximately 6.9% of the class of securities.
• TD Bank holds sole voting and dispositive power over 3,269,957 shares, while TDSI holds sole voting and dispositive power over 101,306 shares.
• TD Bank is the sole owner of TDSI and may be deemed to hold an indirect interest in the shares reported by TDSI.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative disclosure of beneficial ownership changes rather than a strategic or financial performance update.

Positives

• The filing clarifies the beneficial ownership of a significant financial institution in UroGen Pharma Ltd.
• The reporting entities (TD Bank and TDSI) are established financial institutions, suggesting a potentially stable investment.

Negatives

• The filing does not provide any financial performance data or strategic updates for UroGen Pharma Ltd.
• The disclosure is primarily administrative and does not offer insights into the company's operational health or future prospects.

Risks

• The filing does not explicitly mention any risks associated with UroGen Pharma Ltd.'s operations or the investment itself.
• Potential risks could include market volatility affecting the value of the ordinary shares held by TD Bank and TDSI.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding UroGen Pharma Ltd.'s future performance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates a substantial investment by a major Canadian financial institution in a pharmaceutical company.

Related Party Transactions

• TD Bank is the sole owner of TDSI, and TD Bank may be deemed to hold an indirect interest in the shares reported herein by TDSI by virtue of its ownership of TDSI. TD Bank disclaims ownership of the shares reported herein by TDSI except to the extent of its pecuniary interest therein.

Stakeholder Impact

• Shareholders of UroGen Pharma Ltd. are informed of the significant stake held by TD Bank and TDSI, which could influence market perception.
• Creditors and other stakeholders are provided with information regarding the ownership structure of the company.

Next Steps

• The Toronto-Dominion Bank and TD Securities Inc. will continue to hold their beneficial ownership of UroGen Pharma Ltd. ordinary shares.
• Future filings may be required if there are significant changes in their beneficial ownership.

Key Dates

Keywords

UroGen Pharma, Schedule 13G, beneficial ownership, The Toronto-Dominion Bank, TD Securities Inc., ordinary shares, ownership disclosure